Document is current
Any future updates will be listed below
-
Authors
Wheaton, Lorna
Gsteiger, Sandro
Hubbard, Stephanie
Bujkiewicz, Sylwia
-
Funding
Funding for this research was provided by:
Wellcome Trust
Medical Research Council (MR/T025166/1)
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 13 February 2025
First Online: 2 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: SB is a member of the NICE Decision Support Unit (DSU) and the NICE Guidelines Technical Support Unit (TSU). She has served as a paid consultant to NICE, CROs and pharmaceutical industry providing unrelated methodological advice, has received payments for educational events from Roche and the University of Bristol, funding to attend conferences from CROs and Roche, research funding from European Federation of Pharmaceutical Industries & Associations (EEPIA) and Johnson & Johnson and research support in kind from AstraZeneca and Roche. SG is an employee of F. Hoffman-La Roche AG and holds shares of F. Hoffman-La Roche AG, Novartis AG, and Sandoz Group AG. LW and SH have no competing interests to declare.
